These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

514 related articles for article (PubMed ID: 12086864)

  • 1. Wnt5a signaling directly affects cell motility and invasion of metastatic melanoma.
    Weeraratna AT; Jiang Y; Hostetter G; Rosenblatt K; Duray P; Bittner M; Trent JM
    Cancer Cell; 2002 Apr; 1(3):279-88. PubMed ID: 12086864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. WNT5A induces release of exosomes containing pro-angiogenic and immunosuppressive factors from malignant melanoma cells.
    Ekström EJ; Bergenfelz C; von Bülow V; Serifler F; Carlemalm E; Jönsson G; Andersson T; Leandersson K
    Mol Cancer; 2014 Apr; 13():88. PubMed ID: 24766647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A t-butyloxycarbonyl-modified Wnt5a-derived hexapeptide functions as a potent antagonist of Wnt5a-dependent melanoma cell invasion.
    Jenei V; Sherwood V; Howlin J; Linnskog R; Säfholm A; Axelsson L; Andersson T
    Proc Natl Acad Sci U S A; 2009 Nov; 106(46):19473-8. PubMed ID: 19901340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Constitutive activation of Wnt/beta-catenin signaling pathway in migration-active melanoma cells: role of LEF-1 in melanoma with increased metastatic potential.
    Murakami T; Toda S; Fujimoto M; Ohtsuki M; Byers HR; Etoh T; Nakagawa H
    Biochem Biophys Res Commun; 2001 Oct; 288(1):8-15. PubMed ID: 11594745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Importance of P-cadherin, beta-catenin, and Wnt5a/frizzled for progression of melanocytic tumors and prognosis in cutaneous melanoma.
    Bachmann IM; Straume O; Puntervoll HE; Kalvenes MB; Akslen LA
    Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8606-14. PubMed ID: 16361544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SKI activates Wnt/beta-catenin signaling in human melanoma.
    Chen D; Xu W; Bales E; Colmenares C; Conacci-Sorrell M; Ishii S; Stavnezer E; Campisi J; Fisher DE; Ben-Ze'ev A; Medrano EE
    Cancer Res; 2003 Oct; 63(20):6626-34. PubMed ID: 14583455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wnt5A activates the calpain-mediated cleavage of filamin A.
    O'Connell MP; Fiori JL; Baugher KM; Indig FE; French AD; Camilli TC; Frank BP; Earley R; Hoek KS; Hasskamp JH; Elias EG; Taub DD; Bernier M; Weeraratna AT
    J Invest Dermatol; 2009 Jul; 129(7):1782-9. PubMed ID: 19177143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Preparation of the recombinant lentiviral expression vector targeting human Wnt5a gene and its inhibitory effect on melanoma cell invasion].
    Zhao Y; Miao Y; Chen X; Wang L; Lu F; Liao W
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 May; 30(5):462-5. PubMed ID: 24796738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heparan sulfate proteoglycan modulation of Wnt5A signal transduction in metastatic melanoma cells.
    O'Connell MP; Fiori JL; Kershner EK; Frank BP; Indig FE; Taub DD; Hoek KS; Weeraratna AT
    J Biol Chem; 2009 Oct; 284(42):28704-12. PubMed ID: 19696445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Wnt5A/protein kinase C pathway mediates motility in melanoma cells via the inhibition of metastasis suppressors and initiation of an epithelial to mesenchymal transition.
    Dissanayake SK; Wade M; Johnson CE; O'Connell MP; Leotlela PD; French AD; Shah KV; Hewitt KJ; Rosenthal DT; Indig FE; Jiang Y; Nickoloff BJ; Taub DD; Trent JM; Moon RT; Bittner M; Weeraratna AT
    J Biol Chem; 2007 Jun; 282(23):17259-71. PubMed ID: 17426020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autonomous regulation of osteosarcoma cell invasiveness by Wnt5a/Ror2 signaling.
    Enomoto M; Hayakawa S; Itsukushima S; Ren DY; Matsuo M; Tamada K; Oneyama C; Okada M; Takumi T; Nishita M; Minami Y
    Oncogene; 2009 Sep; 28(36):3197-208. PubMed ID: 19561643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The small GTPase ARF6 stimulates β-catenin transcriptional activity during WNT5A-mediated melanoma invasion and metastasis.
    Grossmann AH; Yoo JH; Clancy J; Sorensen LK; Sedgwick A; Tong Z; Ostanin K; Rogers A; Grossmann KF; Tripp SR; Thomas KR; D'Souza-Schorey C; Odelberg SJ; Li DY
    Sci Signal; 2013 Mar; 6(265):ra14. PubMed ID: 23462101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenylmethimazole decreases Toll-like receptor 3 and noncanonical Wnt5a expression in pancreatic cancer and melanoma together with tumor cell growth and migration.
    Schwartz AL; Malgor R; Dickerson E; Weeraratna AT; Slominski A; Wortsman J; Harii N; Kohn AD; Moon RT; Schwartz FL; Goetz DJ; Kohn LD; McCall KD
    Clin Cancer Res; 2009 Jun; 15(12):4114-22. PubMed ID: 19470740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Wnt5a promotes human colon cancer cell migration and invasion but does not augment intestinal tumorigenesis in Apc1638N mice.
    Bakker ER; Das AM; Helvensteijn W; Franken PF; Swagemakers S; van der Valk MA; ten Hagen TL; Kuipers EJ; van Veelen W; Smits R
    Carcinogenesis; 2013 Nov; 34(11):2629-38. PubMed ID: 23764752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wnt5a induces endothelial inflammation via beta-catenin-independent signaling.
    Kim J; Kim J; Kim DW; Ha Y; Ihm MH; Kim H; Song K; Lee I
    J Immunol; 2010 Jul; 185(2):1274-82. PubMed ID: 20554957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assaying Wnt5A-mediated invasion in melanoma cells.
    O'Connell MP; French AD; Leotlela PD; Weeraratna AT
    Methods Mol Biol; 2008; 468():243-53. PubMed ID: 19099260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of membranous expression of beta-catenin is associated with tumor progression in cutaneous melanoma and rarely caused by exon 3 mutations.
    Demunter A; Libbrecht L; Degreef H; De Wolf-Peeters C; van den Oord JJ
    Mod Pathol; 2002 Apr; 15(4):454-61. PubMed ID: 11950921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laminin gamma2 mediates Wnt5a-induced invasion of gastric cancer cells.
    Yamamoto H; Kitadai Y; Yamamoto H; Oue N; Ohdan H; Yasui W; Kikuchi A
    Gastroenterology; 2009 Jul; 137(1):242-52, 252.e1-6. PubMed ID: 19582886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wnt5a is strongly expressed at the leading edge in non-melanoma skin cancer, forming active gradients, while canonical Wnt signalling is repressed.
    Pourreyron C; Reilly L; Proby C; Panteleyev A; Fleming C; McLean K; South AP; Foerster J
    PLoS One; 2012; 7(2):e31827. PubMed ID: 22384081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wnt5A promotes an adaptive, senescent-like stress response, while continuing to drive invasion in melanoma cells.
    Webster MR; Xu M; Kinzler KA; Kaur A; Appleton J; O'Connell MP; Marchbank K; Valiga A; Dang VM; Perego M; Zhang G; Slipicevic A; Keeney F; Lehrmann E; Wood W; Becker KG; Kossenkov AV; Frederick DT; Flaherty KT; Xu X; Herlyn M; Murphy ME; Weeraratna AT
    Pigment Cell Melanoma Res; 2015 Mar; 28(2):184-95. PubMed ID: 25407936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.